Zealand Pharma A/S ZEAL

$ 17.47 0.52%

Annual report 2021
added 12-23-2023

Zealand Pharma A/S Balance Sheet 2011-2024 | ZEAL

Annual Balance Sheet Zealand Pharma A/S

	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-990 M	-	-	-861 M	-453 M	8.91 M	-106 M	-266 M	-286 M	-359 M	-278 M
Long Term Debt	125 M	-	-	-	133 M	329 M	313 M	267 M	-	-	-
Long Term Debt Current	14.9 M	14.1 M	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	806 M	170 M	162 M	-	133 M	329 M	313 M	267 M	-	-	-
Total Current Liabilities	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	1.14 B	533 M	357 M	114 M	209 M	416 M	382 M	344 M	30.8 M	30 M	28.1 M
Deferred Revenue	-	53.2 M	56.3 M	-	-	-	2.09 M	14.4 M	2.33 M	5.07 M	9.28 M
Retained Earnings	-3.31 B	-2.32 B	-1.44 B	-894 M	-1.46 B	-1.19 B	228 M	230 M	293 M	468 M	418 M
Total Assets	2.07 B	1.76 B	1.6 B	1.23 B	737 M	695 M	635 M	597 M	347 M	521 M	469 M
Cash and Cash Equivalents	1.13 B	960 M	1.08 B	861 M	-	-	-	-	-	-	-
Book Value	928 M	1.23 B	1.24 B	1.12 B	528 M	278 M	252 M	253 M	316 M	491 M	441 M
Total Shareholders Equity	928 M	1.23 B	1.24 B	1.12 B	-	-	-	-	-	-	-

All numbers in DKK currency

Quarterly Balance Sheet Zealand Pharma A/S

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	-	-	-	125 M	-	-	-	116 M	119 M	-	-	78.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	806 M	-	-	-	177 M	176 M	-	-	162 M	-	-	-	-	-	-	-	133 M	-	-	-	329 M	-	-	-	313 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	-	-	-	1.14 B	-	-	-	533 M	469 M	-	-	357 M	-	-	-	114 M	-	-	-	207 M	-	-	-	416 M	-	-	-	383 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-	-	-	-	-3.31 B	-	-	-	-2.29 B	-1.91 B	-	-	-1.44 B	-	-	-	-872 M	-	-	-	-1.45 B	-	-	-	-1.2 B	-	-	-	-1.04 B	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	-	-	-	-	2.07 B	-	-	-	1.76 B	2.06 B	-	-	1.6 B	-	-	-	1.23 B	-	-	-	721 M	-	-	-	683 M	-	-	-	628 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	-	-	-	-	1.13 B	-	-	-	960 M	1.23 B	-	-	1.08 B	1.24 B	-	-	861 M	-	-	-	589 M	-	-	-	323 M	-	-	-	419 M	-	-	-	517 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	-	-	-	-	928 M	-	-	-	1.23 B	1.59 B	-	-	1.24 B	-	-	-	1.12 B	-	-	-	515 M	-	-	-	267 M	-	-	-	245 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-	-	-	-	928 M	-	-	-	1.23 B	1.59 B	-	-	1.24 B	1.41 B	-	-	1.12 B	-	-	-	515 M	-	-	-	267 M	-	-	-	245 M	-	-	-	253 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in DKK currency